Your browser doesn't support javascript.
loading
External Beam Radiotherapy in the Management of Uveal Melanoma.
Yilmaz, Melek Tugce; Sari, Sezin Yuce; Zorlu, Faruk; Yazici, Gozde.
Afiliación
  • Yilmaz MT; Hacettepe University Faculty of Medicine, Department of Radiation Oncology, Ankara, Turkey.
  • Sari SY; Hacettepe University Faculty of Medicine, Department of Radiation Oncology, Ankara, Turkey.
  • Zorlu F; Hacettepe University Faculty of Medicine, Department of Radiation Oncology, Ankara, Turkey.
  • Yazici G; Hacettepe University Faculty of Medicine, Department of Radiation Oncology, Ankara, Turkey. yazicig@gmail.com.
Curr Treat Options Oncol ; 25(7): 932-951, 2024 Jul.
Article en En | MEDLINE | ID: mdl-38869695
ABSTRACT
OPINION STATEMENT Uveal melanoma is the most common primary ocular tumor in adults. With the evidence demonstrating that episcleral plaque brachytherapy (EPB) has similar survival rates as enucleation in the Collaborative Ocular Melanoma Study (COMS), eye-sparing treatments have come to the fore today. External radiotherapy techniques (proton beam radiotherapy and stereotactic radiosurgery/fractionated stereotactic radiosurgery) are an important treatment option for globe-sparing treatments. There are no prospective randomized trials comparing these techniques; however, retrospective series, meta-analyses, and reviews indicate that these EPB and external radiotherapy techniques are equal. With this review, we aimed to examine the external radiotherapy techniques used in the treatment of uveal melanoma in detail with reference to the current literature.
Asunto(s)
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Úvea / Braquiterapia / Radiocirugia / Manejo de la Enfermedad / Melanoma Idioma: En Revista: Curr Treat Options Oncol Asunto de la revista: NEOPLASIAS Año: 2024 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Úvea / Braquiterapia / Radiocirugia / Manejo de la Enfermedad / Melanoma Idioma: En Revista: Curr Treat Options Oncol Asunto de la revista: NEOPLASIAS Año: 2024 Tipo del documento: Article